Connect to other sites within the UBM Medica Network
Many RA Patients Maintain Remission at Half Dose of Etanercept
Nearly half of rheumatoid arthritis patients were able to retain remission for 3 months on a 25 mg weekly dose plus methotrexate. Returning to full dose quickly resolved disease for those who flared.
Statin May Put the Brakes on Artery Hardening in AS, RA
Patients with rheumatoid arthritis face an increased risk for acute coronary syndromes, but a popular statin seems to reduce asymptomatic carotid plaques.
IV to Subcutaneous Switch OK for Tocilizumab
More good news for Actemra: rheumatoid arthritis patients can safely transition from the intravenous form of the IL-16 blocker to the injectable version.
Rheumatology and Rashes: Insights from the AAD Annual Meeting
Lupus is the condition that most frequently requires attention to skin problems, but it's far from the only reason for a rheumatologist's patient to see a dermatologist. In the case of lupus, however, the lesion may be a clue to prognosis.
Can ACPA Predict Long-Term Remission in RA?
Two new studies show that ACPA-positive rheumatoid arthritis patients are substantially less likely to sustain remission after drug tapering or withdrawal.
Fatigue, Common in RA, Traced to Factors Beyond Inflammation
Chronic fatigue, extraordinarily common in autoimmune diseases such as rheumatoid arthritis, remains poorly defined. New studies suggest that disease activity is not the only contributing factor.
Free For All: Rheumatology Textbook by Cush, Kavanaugh, and Stein
Three eminent rheumatologists have posted their comprehensive textbook of rheumatology online, open-access and free. They are calling it Rheumaknowledgy.
By clicking Accept, you agree to become a member of the UBM Medica Community.